Clinical trial
Clinical Utility of Endothelial Dysfunction in PAD
NCT00491751 · Boston University, Other · Terminated
Key facts
| NCT number | NCT00491751 |
|---|---|
| Title | Clinical Utility of Endothelial Dysfunction in PAD |
| Official title | Clinical Utility of Endothelial Dysfunction in PAD |
| Lead sponsor | Boston University, Other |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Peripheral Arterial Disease |
| Intervention type | Drug |
| Interventions | atorvastatin, ascorbic acid, Placebo |
| Enrollment | 108 |
| Start date | May 1, 2004 |
| Primary completion | Jun 1, 2012 |
| Completion | Jun 1, 2012 |
| First posted | Jun 26, 2007 |
| Last update posted | Jul 27, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: